Barinthus Biotherapeutics Investor Relations Material
Latest events
Q2 2025
7 Aug, 2025
Q1 2025
7 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Barinthus Biotherapeutics plc
Access all reports
Barinthus Biotherapeutics plc is a biotechnology company focused on the development of novel immunotherapies for infectious diseases and cancer. The company specializes in T-cell activating therapeutics and next-generation vaccine platforms designed to enhance immune response. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
BRNS
Country
🇺🇸 United States